ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published online before print April 26, 2006, 10.1183/09031936.06.00002606
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barrett, B.
Right arrow Articles by Turner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barrett, B.
Right arrow Articles by Turner, R.
Eur Respir J 2006; 28:358-361
Copyright ©ERS Journals Ltd 2006

Relations among questionnaire and laboratory measures of rhinovirus infection

B. Barrett1, R. Brown1, R. Voland1, R. Maberry1 and R. Turner2

1 University of Wisconsin, Madison, Madison, WI, and 2 University of Virginia, Charlottesville, VI, USA.

CORRESPONDENCE: B. Barrett, Dept of Family Medicine, University of Wisconsin Medical School, 777 S. Mills, Madison WI 53715, USA. Fax: 1 6082635813. E-mail: bruce.barrett{at}fammed.wisc.edu

Keywords: Common cold, quality of life, questionnaires, rhinovirus, upper respiratory infection, validation

Received: January 7, 2006
Accepted April 8, 2006

Due to high incidence and quality-of-life impact, upper respiratory infection substantially impacts on population health. To test or compare treatment effectiveness, a well-designed and validated illness-specific quality-of-life instrument is needed.

Data reported in the current study were obtained from a trial testing echinacea for induced rhinovirus infection. Laboratory-assessed biomarkers included interleukin (IL)-8, nasal neutrophil count (polymorphonuclear neutrophils (PMN)), mucus weight, viral titre and seroconversion. The questionnaires used included the general health short form (SF)-8 (24-h recall version), the eight-item Jackson cold scale, and the 44-item Wisconsin Upper Respiratory Symptom Survey (WURSS).

In total, 399 participants were inoculated with rhinovirus and monitored over 2,088 person-days. Statistically significant associations were found among nearly all variables. Between-questionnaire correlations were: WURSS–Jackson = 0.81; WURSS–SF-8 = 0.62; and Jackson–SF-8 = 0.60. Correlations with laboratory values were as follows: WURSS–mucus weight = 0.53; Jackson–mucus weight = 0.55; WURSS–viral titre = 0.37; Jackson–viral titre = 0.46; WURSS–IL-8 = 0.31; Jackson–IL-8 = 0.36; WURSS–PMN = 0.31; and Jackson–PMN = 0.28. Neither WURSS nor Jackson yielded satisfactory cut-off scores for diagnosis of infection.

Symptomatic and biological outcomes of upper respiratory infection are highly variable, with only modest associations. While Wisconsin Upper Respiratory Symptom Survey and Jackson questionnaires both correlate with biomarkers, neither is a good predictor of induced infection. The inclusion of functional and quality-of-life items in the Wisconsin Upper Respiratory Symptom Survey does not significantly decrease the strength of association with laboratory-assessed biomarkers.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the European Respiratory Society.